4.7 Article

Synthesis and biological evaluation of arctigenin ester and ether derivatives as activators of AMPK

Journal

BIOORGANIC & MEDICINAL CHEMISTRY
Volume 21, Issue 13, Pages 3882-3893

Publisher

PERGAMON-ELSEVIER SCIENCE LTD
DOI: 10.1016/j.bmc.2013.04.010

Keywords

Arctigenin; 9-Deoxy-arctigenin; AMPK; 2-(3,4-Dimethoxyphenyl)ethyl

Funding

  1. National Natural Science Foundation of China [30925040, 81102329, 81273430]
  2. Chinese National Science & Technology Major Project 'Key New Drug Creation and Manufacturing Program' [2013ZX09508104, 2012ZX09301001-001, 2011ZX09307-002-03]
  3. Science Foundation of Shanghai [12XD14057]
  4. State Key Laboratory of Natural and Biomimetic Drugs [K20120220]

Ask authors/readers for more resources

A series of new arctigenin and 9-deoxy-arctigenin derivatives bearing different ester and ether side chains at the phenolic hydroxyl positions are designed, synthesized, and evaluated for activating AMPK potency in L6 myoblasts. Initial biological evaluation indicates that some alkyl ester and phenethyl ether arctigenin derivatives display potential activities in AMPK phosphorylation improvement. Further structure-activity relationship analysis shows that arctigenin ester derivatives 3a, 3h and 9-deoxy-arctigenin phenethyl ether derivatives 6a, 6c, 6d activate AMPK more potently than arctigenin. Moreover, the 2-(3,4-dimethoxyphenyl)ethyl ether moiety of 6c has been demonstrated as a potential functional group to improve the effect of AMPK phosphorylation. The structural optimization of arctigenin leads to the identification of 6c as a promising lead compound that exhibits excellent activity in AMPK activation. (C) 2013 The Authors. Published by Elsevier Ltd. All rights reserved.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available